Isotretinoin Use in Transmasculine Patients and Its Implication on Chest Masculinization Surgery: Scoping Review of the Literature.

Daniel M Strock Torunn Elise Sivesind Robert Paul Dellavalle Gerhard S Mundinger

Published in: JMIR dermatology (2023)

Further studies are required to strengthen the current evidence that suggests that isotretinoin does not need to be discontinued before or after incisional or excisional surgeries, including chest masculinization surgery in transmasculine patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
chronic kidney disease
prognostic factors
systematic review
coronary artery bypass
patient reported outcomes
surgical site infection
coronary artery disease
acute coronary syndrome
atrial fibrillation